The Antiobesity market size is expected to reach $6.56 billion in 2030 at a CAGR of 10.0%, driven by rising obesity prevalence and growing adoption of hormone-based weight loss drugs.
Read More
The Anti-Neoplastic Agents market size is expected to reach $227.48 billion in 2030 at a CAGR of 9.9%, driven by increasing cancer cases and expansion of precision oncology therapies.
Read More
The Antimetabolite Drug market size is expected to reach $12.23 billion in 2030 at a CAGR of 4.5%, driven by rising global cancer incidence and continued oncology treatment demand.
Read More
The Anti-Inflammatory Therapeutics market size is expected to reach $152.04 billion in 2030 at a CAGR of 5.6%, driven by growing inflammatory bowel disease prevalence.
Read More
The Anti-Inflammatory Drugs market size is expected to reach $252.87 billion in 2030 at a CAGR of 10.6%, driven by increasing arthritis cases and demand for long-term pain management solutions.
Read More
The Anti-Inflammatory Biologics market size is expected to reach $180.93 billion in 2030 at a CAGR of 8.9%, driven by rising arthritis prevalence and adoption of targeted biologic therapies.
Read More
The Anti-Hypertensive Drugs market size is expected to reach $41.72 billion in 2030 at a CAGR of 2.0%, driven by rising cardiovascular disease prevalence.
Read More
The Antiglaucoma Drugs market size is expected to reach $24.51 billion in 2030 at a CAGR of 7.3%, driven by aging populations and increasing prevalence of vision impairment and myopia.
Read More
The Antifungals market size is expected to reach $44.96 billion in 2030 at a CAGR of 8.9%, driven by rising fungal infection prevalence and expanding global healthcare infrastructure.
Read More
The Antifibrinolytic Drugs market size is expected to reach $23.54 billion in 2030 at a CAGR of 5.6%, driven by rising surgical procedures and demand for effective blood loss management.
Read More